Air Canada (TSX:AC) is too speculative for Warren Buffett to own amid this pandemic, but that doesn’t mean you should avoid shares too, especially if you’re a young long-term investor who has a strong stomach.
Indeed, there is a wide range of possibilities with this pandemic. Many health experts agree that an effective coronavirus vaccine will be available at some point in 2021. Some optimistic analysts, including those at Goldman Sachs, see an approved vaccine landing in the latter part of 2020. Once a vaccine does land, the airlines could correct very suddenly to the upside, as bankruptcy fears fade.
The bear case with the airlines
In the meantime, many airlines are going to be fighting for their lives. And if most analysts are wrong and a vaccine doesn’t arrive until 2022 or later, Air Canada and its peers could stand to decline further en route to zero.
While Air Canada does have a decent liquidity position today, if a bear-case scenario happens with this pandemic, and the world economy is to fall into a depression, even a stellar liquidity positioning won’t be able to avert insolvency. There’s no telling how long fiscal and monetary stimuli can keep airlines and other zombie companies alive through this pandemic.
Companies can’t keep borrowing money forever. If COVID-19 keeps a majority of travellers out of the air for far longer than expected, there’s no question that you could lose a majority, if not all, of your Air Canada investment if worse comes to worst. Given the high downside risk, it may or may not make sense to bet on an airline comeback if you’re not a fan of volatility or speculation.
With little visibility into the pandemic timeline, airlines remain nearly impossible to value. But if the most likely scenario occurs and we are due for a COVID-19 vaccine in the middle of next year, airline stocks could prove to be severely undervalued right now.
No surprises here: Air Canada had a rough second quarter
As expected, Air Canada clocked in a brutal second quarter, as it scrambled to raise and conserve cash to buy it time to wait for the advent of a vaccine. The company posted a wider-than-expected net loss of $6.44 per share, enticing some analysts to lower their targets on the ailing airline. Revenues nosedived almost 89% thanks to a capacity decline that exceeded 90%.
Given Air Canada derives a considerable chunk of its normalized revenues from international flights, the Canadian airline faces an uphill battle on the road to recovery.
Fortunately, Air Canada is doing a great job of reducing operating expenses, which declined over 40% since the last quarter. Cash burn rates are falling, and they’re expected to continue dropping into year-end. With a decent liquidity positioning versus its U.S. peers, many of which embarrassingly blew a tonne of cash on share buybacks over the years, Air Canada looks poised to make it out of this crisis under its own power if we get a vaccine in mid-2021.
Moreover, I’m of the belief that the travel industry will rebound a lot quicker than most analysts expect once the masses can get vaccinated. Recession or not, there’s likely going to be pent-up demand for air travel once it’s finally safe to take the skies. Although the downside risk is massive, I view Air Canada, with its above-average balance sheet, as a speculation bet that’s tilted ever so slightly in favour of the investor.
Foolish takeaway on Air Canada
If you’re young, with disposable TFSA cash that’s collecting dust in a savings account, it may make sense to nibble on Air Canada, as the upside potential, I believe, more than makes up for the downside risks if you’re bullish on the advent of a vaccine by 2021.
Speaking of ample upside, you need to check out these following stocks curated by the team here at the Motley Fool Canada!
Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Joey Frenette has no position in any of the stocks mentioned.